Nelson Spector
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 32
- Chronic Lymphocytic Leukemia Research 27
- Hematology 25
- Chronic Myeloid Leukemia Treatments 14
- Co-authors
- Jorge I. SalluhMárcio SoaresMárcio NucciWolmar PulcheriIrène BiasoliJosé Rodolfo RoccoJosé Carlos MoraisFernanda Silveira
- Journals
- Oncology Reports (7 papers)Clinical Infectious Diseases (6 papers)Journal of Clinical Oncology (6 papers)Blood (6 papers)Supportive Care in Cancer (3 papers)
- Partner nations
- BrazilUnited StatesSpain
In The Last Decade
Nelson Spector
100 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 112
- Hematology 398
- Critical Care and Intensive Care Medicine 183
- Genetics 317
- Oncology 811
- Infectious Diseases 490
Countries citing papers authored by Nelson Spector
This map shows the geographic impact of Nelson Spector's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson Spector with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson Spector more than expected).
Fields of papers citing papers by Nelson Spector
This network shows the impact of papers produced by Nelson Spector. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson Spector. The network helps show where Nelson Spector may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nelson Spector, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2017 | 31 | |
| 3 | 2015 | 2 | |
| 4 | 2015 | 60 | |
| 5 | 2014 | 14 | |
| 6 | Nilotinib induces deeper molecular responses vs continued imatinib in patients with ph+ chronic myeloid leukemia (CML) with detectable disease after ≥ 2 years on imatinib: ENESTcmr 12-months results | 2012 | 0 |
| 7 | 2012 | 2 | |
| 8 | 2009 | 12 | |
| 9 | 2006 | 91 | |
| 10 | 2005 | 112 | |
| 11 | 2003 | 19 | |
| 12 | 2000 | 12 | |
| 13 | 1999 | 3 | |
| 14 | Linfomas MALT do estomago: estudo clinicopatologico de 30 pacientes submetidos a gastrectomia | 1998 | 1 |
| 15 | 1998 | 13 | |
| 16 | 1998 | 3 | |
| 17 | 1998 | 61 | |
| 18 | 1997 | 59 | |
| 19 | 1995 | 8 | |
| 20 | 1995 | 61 |
About Nelson Spector
Nelson Spector is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Clinical Biochemistry, having authored 104 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (27 papers), Neutropenia and Cancer Infections (18 papers), Chronic Myeloid Leukemia Treatments (14 papers), Viral-associated cancers and disorders (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Antifungal resistance and susceptibility (7 papers). The work is most often cited by research in Hematology (398 citations), Critical Care and Intensive Care Medicine (183 citations), Genetics (317 citations), Oncology (811 citations) and Infectious Diseases (490 citations). Nelson Spector has collaborated with scholars based in Brazil, United States and Spain. Frequent co-authors include Jorge I. Salluh, Márcio Soares, Márcio Nucci, Wolmar Pulcheri, Irène Biasoli, José Rodolfo Rocco, José Carlos Morais, Fernanda Silveira, Arnaldo Lopes Colombo and Carlos Gil Ferreira. Their work appears in journals such as Oncology Reports, Clinical Infectious Diseases, Journal of Clinical Oncology, Blood and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.